RecruitingNCT06725173

Detailed Phenotypic and Genotype Study to Correlate RB1 Mutations Relating to Primary Ocular Tumors and Secondary Extra-ocular Metastasis.

Studying Hereditary retinoblastoma

Last synced from ClinicalTrials.gov April 1, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: University of Washington
Principal Investigator: Debarshi Mustafi, MD PhD
University of Washington
Intervention: Targeted Long-read sequencing(genetic)
Enrollment: 100 enrolled
Eligibility: All sexes
Timeline: 2026 – 2031

Study locations (1)

University of Washington, Seattle, Washington, United States

Collaborators

National Eye Institute (NEI)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06725173 on ClinicalTrials.gov

Other trials for Hereditary retinoblastoma

Additional recruiting or active studies for the same condition.

See all trials for Hereditary retinoblastoma →

← Back to all trials